Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on European Global Times.
Press releases published on May 12, 2025
Deutschlands und Österreichs erste sichere und kosteneffiziente Möglichkeit, in Krypto – Perpetual Futures zu investieren jetzt für Privatanleger in Europa verfügbar
GlobeNewswire
·
May 12, 2025
Der regulierte Handelsplatz One Trading startet EU-Onshore für Retail-Investoren. Zum ersten Mal können qualifizierende Privatanleger aus Deutschland und Österreich Long und Short in bar abgerechneten Bitcoin- und Ethereum-Perpetual Futures traden. One …
Nokia enhances Optus’s 5G network with improved capacity and coverage across regional Australia
GlobeNewswire
·
May 12, 2025
Press Release Nokia enhances Optus’s 5G network with improved capacity and coverage across regional Australia Nokia to deploy its high-performance, energy-efficient Habrok Massive MIMO radios and Levante baseband solutions to boost the coverage and …
Publication of Prospectus
GlobeNewswire
·
May 12, 2025
Shell International Finance B.V. and Shell plc 12 May 2025 Publication of Prospectus The following prospectus has been approved by the UK Financial Conduct Authority and is available for viewing: Information Memorandum dated 9 May 2025 relating to the …
Best Crypto Casinos UK: Find Out The Top Crypto Casino Of 2025! – JackBit Casino
GlobeNewswire
·
May 12, 2025
LONDON, May 12, 2025 (GLOBE NEWSWIRE) -- After thoroughly assessing several options and setting up strict criteria to evaluate the best crypto casino in the UK, our expert team identified the top platforms excelling in game variety, bonuses, security, and …
CMB.TECH announces Q1 2025 results on 21/05/25
GlobeNewswire
·
May 12, 2025
Antwerp, May 12, 2025 (GLOBE NEWSWIRE) -- CMB.TECH NV (NYSE: CMBT …
AB Science reports its revenues for the year 2024 and provides an update on its activities
GlobeNewswire
·
May 12, 2025
PRESS RELEASE AB SCIENCE PRESENTS ITS FINANCIAL INFORMATION AS OF DECEMBER 31, 2024 AND THE KEY EVENTS OF THE PERIOD Financial and corporate situation Operating deficit of 6,1 million euros as of December 31, 2024, down 55% compared to December 31 …
AB Science annonce ses résultats financiers annuels arrêtés au 31 décembre 2024 et présente un point sur ses activités
GlobeNewswire
·
May 12, 2025
COMMUNIQUE DE PRESSE AB SCIENCE PRÉSENTE SES RÉSULTATS FINANCIERS ANNUELS AU 31 DECEMBRE 2024 ET LES EVENEMENTS CLEFS DE LA PERIODE Situation financière et corporate Déficit opérationnel de 6,1 millions d’euros au 31 décembre 2024 en baisse de 55% …
Nanobiotix participera à la 3ème conférence investisseurs annuelle H.C. Wainwright BioConnect au NASDAQ
GlobeNewswire
·
May 12, 2025
PARIS and CAMBRIDGE, Mass., 12 mai 2025 (GLOBE NEWSWIRE) -- NANOBIOTIX (Euronext : NANO –– NASDAQ : NBTX – la « Société »), société française de biotechnologie en phase de développement clinique avancé, pionnière des approches fondées sur les …
Norsk Hydro: Ex-dividend NOK 2.25 today
GlobeNewswire
·
May 12, 2025
The shares in Norsk Hydro ASA will be traded ex-dividend of NOK 2.25 as from today, May 12, 2025. Investor contact: Elitsa Blessi +47 91775472 Elitsa.Blessi@hydro.com This information is subject to the disclosure requirements pursuant to Section 5-12 …
Norsk Hydro: Eksklusive utbytte kr 2,25 i dag
GlobeNewswire
·
May 12, 2025
Aksjene i Norsk Hydro ASA handles eksklusive utbytte på 2,25 kroner fra og med i dag, 12. mai 2025. Investorkontakt: Elitsa Blessi +47 91775472 Elitsa.Blessi@hydro.com Denne opplysningen er informasjonspliktig etter verdipapirhandelloven §5-12
Nanobiotix to Participate in the H.C. Wainwright 3rd Annual BioConnect Investor Conference at NASDAQ
GlobeNewswire
·
May 12, 2025
PARIS and CAMBRIDGE, Mass., May 12, 2025 (GLOBE NEWSWIRE) -- NANOBIOTIX (Euronext: NANO –– NASDAQ: NBTX – the ‘‘Company’’), a late-clinical stage biotechnology company pioneering nanoparticle-based approaches to expand treatment possibilities for patients …
Technip Energies Announces Launch of Share Buy-Back Program
GlobeNewswire
·
May 12, 2025
Technip Energies (PARIS:TE) (the “Company”), a global technology …
Jeito Capital Strengthens Leadership for Next Chapter of Growth: Mehdi Ainouche Promoted to Partner, Julien Elric to Senior Principal
GlobeNewswire
·
May 12, 2025
Paris, May 12, 2025 - Jeito Capital (“Jeito”), a global leading independent Private Equity fund dedicated to biopharma, is pleased to announce the promotion of Mehdi Ainouche to Partner and Julien Elric to Senior Principal. These promotions represent the …
Technip Energies annonce le lancement d'un programme de rachat d'actions
GlobeNewswire
·
May 12, 2025
Technip Energies (PARIS:TE) (la « Société »), une entreprise de technologie et d’ingénierie de premier plan dans les infrastructures énergétiques et de décarbonation, annonce aujourd'hui le lancement d'un programme de rachat d'actions pouvant atteindre 45 …
Addex Partner Indivior Advances GABAB Positive Allosteric Modulator Program Successfully Through IND Enabling Studies
GlobeNewswire
·
May 12, 2025
Ad Hoc Announcement Pursuant to Art. 53 LR Geneva, Switzerland, May 12, 2025 - Addex Therapeutics (SIX/NASDAQ: ADXN), a clinical-stage biopharmaceutical company focused on developing a portfolio of novel small molecule allosteric modulators for …
Valneva Provides Update on Recommended Use of IXCHIQ® by Elderly Individuals in the United States
GlobeNewswire
·
May 12, 2025
Saint Herblain (France), May, 12 2025 – Valneva SE (Nasdaq: VALN; Euronext Paris: VLA), a specialty vaccine company, today announced that the U.S. Food and Drug Association (FDA) and the U.S. Centers for Disease Control and Prevention (CDC), in a joint …
Valneva fait un point sur les recommandations d’utilisation d'IXCHIQ® chez les personnes âgées aux États-Unis
GlobeNewswire
·
May 12, 2025
Saint Herblain (France), le 12 mai 2025 – Valneva SE (Nasdaq : VALN ; Euronext Paris : VLA), société spécialisée dans les vaccins, a annoncé aujourd'hui que l’agence de santé américaine Food and Drug Administration (FDA) et les centres américains de …
Zealand Pharma to participate in upcoming healthcare investor conferences in May and June 2025
GlobeNewswire
·
May 12, 2025
Press release – No. 8 / 2025 Zealand Pharma to participate in upcoming healthcare investor conferences in May and June 2025 Copenhagen, Denmark, May 12, 2025 – Zealand Pharma A/S (Nasdaq: ZEAL) (CVR-no. 20045078), a biotechnology company focused on the …